1. Tabbara KF. Tuberculosis. Curr Opin Ophthalmol. 1961; 66:111–24.
2. Sheu SJ, Shyu JS, Chen LM, et al. Ocular manifestations of tuberculosis. Ophthalmology. 1961; 66:111–24.
Article
3. Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 1961; 66:111–24.
Article
4. Gupta V, Gupta A, Arora S, et al. Presumed tubercular serpiginous-like choroiditis: clinical presentations and management. Opthalmology. 1961; 66:111–24.
5. Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weak-nesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. 1961; 66:111–24.
Article
6. Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tu-bercular uveitis. Am J Ophthalmol. 1961; 66:111–24.
Article
7. Vasconcelos-Santos DV, Rao PK, Davies JB, et al. Clinical features of tuberculous serpiginouslike choroiditis in contrast to classic ser-piginous choroiditis. Arch Ophthalmol. 1961; 66:111–24.
Article
8. World Health Organization. Global tuberculosis report 2015. 20th ed.Geneva: World Health Organization;2015; 1–7.
9. Sarvananthan N, Wiselka M, Bibby K. Intraocular tuberculosis without detectable systemic infection. Arch Ophthalmol. 1998; 116:1386–8.
10. Stechschulte SU, Kim RY, Cunningham ET Jr. Tuberculous neuroretinitis. J Neuroophthalmol. 1961; 66:111–24.
Article
11. Kotake S, Kimura K, Yoshikawa K, et al. Polymerase chain re-action for the detection of Mycobacterium tuberculosis in ocular tuberculosis. Am J Ophthalmol. 1961; 66:111–24.
Article
12. Lee JY, Kang KW, Shin JP, et al. Rapidly progressing foveal atro-phy with tuberculous serpiginous-like choroiditis despite com-bined anti-tuberculosis and steroid Treatment. J Korean Ophthalmol Soc. 1961; 66:111–24.
Article
13. Biswas J, Madhavan HN, Gopal L, Badrinath SS. Intraocular tuberculosis. Clinicopathologic study of five cases. Retina. 1995; 15:461–8.
Article
14. Barondes MJ, Sponsel WE, Stevens TS, Plotnik RD. Tuberculous choroiditis diagnosed by chorioretinal endobiopsy. Am J Ophthalmol. 1961; 66:111–24.
Article
15. Gupta V, Gupta A, Sachdeva N, et al. Successful management of tubercular subretinal granulomas. Ocul Immunol Inflamm. 2006; 14:35–40.
Article
16. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuber-culin skin tests: what is the absolute effect of BCG and non-tuber-culous mycobacteria? Int J Tuberc Lung Dis. 1961; 66:111–24.
17. Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuber-culosis infection, United States. MMWR Recomm Rep. 2005; 54:49–55.
18. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000; 161:(4 Pt 2). S221–47.
19. Wang L, Turner MO, Elwood RK, et al. A meta-analysis of the ef-fect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 1961; 66:111–24.
20. Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid di-agnostic tests for the detection of tuberculosis infection. Health Technol Assess. 1961; 66:111–24.
Article
21. Jeong YJ, Lee KS. Pulmonary uberculosis: up-to-date imaging and management. AJR Am J Roentgenol. 1961; 66:111–24.
22. Shin CH, Lee SN. Atypical ocular and optical coherence tomo-graphic findings with presumed miliary tuberculosis. J Korean Ophthalmol Soc. 1961; 66:111–24.
Article